Cocrystal Pharma, INC. (COCP) SEC Filings — 2024

Filings

• Cocrystal Pharma Files 8-K with Financials & Reg FD — 8-K · Dec 31, 2024
• Cocrystal Pharma Files 8-K on Financials — 8-K · Nov 13, 2024
• Cocrystal Pharma Files 8-K — 8-K · Oct 31, 2024
• Cocrystal Pharma Appoints New Director, Discloses Officer Compensation — 8-K · Oct 10, 2024
• Cocrystal Pharma Files 8-K on Aug 19 Events — 8-K · Aug 20, 2024
• Cocrystal Pharma Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
• Cocrystal Pharma Files 8-K — 8-K · Jul 18, 2024
• Cocrystal Pharma Files 8-K on Corporate Changes — 8-K · Jun 28, 2024
• Cocrystal Pharma Files 8-K — 8-K · Jun 20, 2024
• Cocrystal Pharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Cocrystal Pharma, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · May 7, 2024
• Cocrystal Pharma Files 8-K — 8-K · May 1, 2024
• Cocrystal Pharma, Inc. Files Amendment to Annual Report — 10-K/A · Apr 17, 2024
• Cocrystal Pharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
• Cocrystal Pharma Files 8-K — 8-K · Mar 19, 2024
• Cocrystal Pharma Terminates Material Agreement — 8-K · Mar 1, 2024
• Cocrystal Pharma Confirms Nasdaq Listing Under COCP — 8-K · Jan 8, 2024
• Cocrystal Pharma 8-K: General Corporate Info, Nasdaq Listing Confirmed — 8-K · Jan 4, 2024
• Sabby Volatility Exits Cocrystal Pharma Position — SC 13G/A · Jan 2, 2024